10-Q Filing

ENVERIC BIOSCIENCES, INC. CIK: 890821 Q2 2016

Filing Information

Form Type	10-Q
Accession Number	`0001079974-15-000809`
Period End Date	20150930
Filing Date	20151123
Fiscal Year	2016
Fiscal Period	Q2
XBRL Instance	amhi-20150930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 66

Balance Sheet 66 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, authorized shares	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Preferred stock, authorized shares	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Preferred stock, issued shares	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, issued shares	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, outstanding shares	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, outstanding shares	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$825.62K	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.07M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$2.98M	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$1.00M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$8.96M	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$1.00M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Other Current Assets	`OtherAssetsCurrent`	$458.33K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Other Current Assets	`OtherAssetsCurrent`	$180.62K	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$3.99M	USD	Point-in-time
Common stock, authorized shares	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$14.48M	USD	Point-in-time
Common stock, authorized shares	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Investments	`Investments`	$340.00K	USD	Point-in-time
Common stock, issued shares	`CommonStockSharesIssued`	11.64M	shares	Point-in-time
Common stock, issued shares	`CommonStockSharesIssued`	9.99M	shares	Point-in-time
Investments	`Investments`	-	USD	Point-in-time
Fixed assets - net	`AssetsNet`	$76.70K	USD	Point-in-time
Common stock, outstanding shares	`CommonStockSharesOutstanding`	11.64M	shares	Point-in-time
Fixed assets - net	`AssetsNet`	$29.91K	USD	Point-in-time
Common stock, outstanding shares	`CommonStockSharesOutstanding`	9.99M	shares	Point-in-time
Intangible assets - net	`FiniteLivedIntangibleAssetsNet`	$100.00K	USD	Point-in-time
Intangible assets - net	`FiniteLivedIntangibleAssetsNet`	$3.16M	USD	Point-in-time
Goodwill	`Goodwill`	-	USD	Point-in-time
Goodwill	`Goodwill`	$3.47M	USD	Point-in-time
Security deposit	`SecurityDeposit`	$20.59K	USD	Point-in-time
Security deposit	`SecurityDeposit`	$3.75K	USD	Point-in-time
Total Assets	`Assets`	$4.46M	USD	Point-in-time
Total Assets	`Assets`	$21.21M	USD	Point-in-time
Line of credit	`LineOfCredit`	-	USD	Point-in-time
Line of credit	`LineOfCredit`	$250.00K	USD	Point-in-time
Accounts Payable	`AccountsPayableCurrent`	$3.56M	USD	Point-in-time
Accounts Payable	`AccountsPayableCurrent`	$2.94M	USD	Point-in-time
Consideration payable	`CededPremiumsPayable`	-	USD	Point-in-time
Consideration payable	`CededPremiumsPayable`	$8.90M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$146.79K	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$1.82M	USD	Point-in-time
Taxes payable	`TaxesPayableCurrent`	$405.22K	USD	Point-in-time
Taxes payable	`TaxesPayableCurrent`	$320.25K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$14.85M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$3.49M	USD	Point-in-time
Contingent consideration payable	`BusinessCombinationContingentConsiderationLiability`	-	USD	Point-in-time
Contingent consideration payable	`BusinessCombinationContingentConsiderationLiability`	$400.00K	USD	Point-in-time
Convertible notes	`ConvertibleLongTermNotesPayable`	-	USD	Point-in-time
Convertible notes	`ConvertibleLongTermNotesPayable`	$5.00M	USD	Point-in-time
Total current and long-term liabilities	`BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt`	$3.49M	USD	Point-in-time
Total current and long-term liabilities	`BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt`	$20.25M	USD	Point-in-time
Common shares, $.01 par value, 300,000,000 shares authorized, 11,639,066 and 9,992,828 issued and outstanding as of September 30, 2015 and March 31, 2015, respectively	`CommonStockValue`	$992.00	USD	Point-in-time
Common shares, $.01 par value, 300,000,000 shares authorized, 11,639,066 and 9,992,828 issued and outstanding as of September 30, 2015 and March 31, 2015, respectively	`CommonStockValue`	$116.39K	USD	Point-in-time
Additional Paid-In Capital	`AdditionalPaidInCapitalCommonStock`	$53.13K	USD	Point-in-time
Additional Paid-In Capital	`AdditionalPaidInCapitalCommonStock`	$134.01K	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$699.46K	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$837.86K	USD	Point-in-time
Cumulative translation adjustment	`TranslationAdjustmentFunctionalToReportingCurrencyNetOfTax`	$89.82K	USD	Point-in-time
Cumulative translation adjustment	`TranslationAdjustmentFunctionalToReportingCurrencyNetOfTax`	-	USD	Point-in-time
Total Stockholders' Equity (Deficit)	`StockholdersEquity`	$958.80K	USD	Point-in-time
Total Stockholders' Equity (Deficit)	`StockholdersEquity`	$972.86K	USD	Point-in-time
Total Liabilities and Stockholders' Equity (Deficit)	`LiabilitiesAndStockholdersEquity`	$4.46M	USD	Point-in-time
Total Liabilities and Stockholders' Equity (Deficit)	`LiabilitiesAndStockholdersEquity`	$21.21M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.